Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermafirm is an active South Korea-origin skincare and aesthetics company commercializing professional and consumer skin, hair, scalp, and wellness products in the U.S. through Dermafirm USA, Inc. The company appears to focus on cosmeceuticals, professional treatment systems, and beauty devices rather than prescription therapeutics or a clinical drug pipeline. Its portfolio includes topical skincare lines such as BIOTOC, RX Hydra Exosome, RX Melavita-C Exosome, and acne-focused products, along with microneedling, LED, plasma, and other spa or at-home devices. Dermafirm markets itself around clean beauty, biotechnology-inspired formulations, and professional aesthetics channels. For a biotech analyst, this is best classified as a commercial dermatology-adjacent skincare/aesthetics company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermafirm.